Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2026-03-06 @ 9:43 AM
Study NCT ID:
NCT02128958
Status:
COMPLETED
Last Update Posted:
2022-10-04
First Post:
2014-04-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Sponsor:
Can-Fite BioPharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CF102-201HCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None